NovoCIB Overview

  • Founded
  • 2005
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $260K
Latest Deal Amount
  • Investors
  • 1

NovoCIB General Information


Provider of innovative enzyme activity assay kits for life scientists and for food quality control. The company produces recombinant enzymes of purine metabolism and also provides analytical services for nucleotide quantification, thereby providing the food industry with rich sources of validated or high-potential targets in oncology, infectiology and immunology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 115, Avenue Lacassagne
  • 69003 Lyon
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NovoCIB Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 01-Nov-2012 $260K 00000 Completed Generating Revenue
To view NovoCIB’s complete valuation and funding history, request access »

NovoCIB Patents

NovoCIB Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-2935003-A1 New ultrasensitive and rapid method for measuring by bioluminescence the degree of freshness of animal flesh Pending 14-Aug-2008 00000000

NovoCIB Executive Team (2)

Name Title Board Seat Contact Info
Larissa Balakireva Co-Founder, Chief Scientific Officer, Chief Executive Officer & President
Nicolas Godard General Manager & Co-Founder
To view NovoCIB’s complete executive team members history, request access »

NovoCIB Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Savoie Angels Angel Group Minority 000 0000 000000 0
To view NovoCIB’s complete investors history, request access »